Wealth Enhancement Advisory Services, LLC Allogene Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 19,260 shares of ALLO stock, worth $32,356. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,260Holding current value
$32,356% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALLO
# of Institutions
175Shares Held
139MCall Options Held
75.8KPut Options Held
52.8K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$31.4 Million1.1% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$27.6 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR10.9MShares$18.3 Million9.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8MShares$13.4 Million0.0% of portfolio
-
State Street Corp Boston, MA7.25MShares$12.2 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $242M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...